A Study Of Signia™ Circular Stapler With Tri-Staple For Left-sided Colon, Sigmoid, And Rectal Resections

Overview

About this study

The primary objective of this study is to evaluate the safety and performance of Signia™ circular stapler, for the creation of anastomoses assessed by the incidence of anastomotic leak within 30 days, following use in subjects undergoing left sided colon, sigmoid, or rectal resections. Specifically, the primary objective is to evaluate if the incidence of anastomotic leak within 30 days is below the performance goal set at 9.3%.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Preoperative Inclusion Criteria

  • Subject is competent and willing to provide documented informed consent to participate in this clinical study.

  • Subject is intended to undergo an elective left sided colon/colorectal procedure where a creation of an anastomosis will be completed with the Signia™ circular stapler.

  • Subject is ≥ 18 years of age at time of consent.

Exclusion Criteria

Preoperative Exclusion Criteria

  • Subject is unable or unwilling to comply with the study requirements or follow-up schedule.

  • Subject with ASA classification ≥ IV.

  • Subject is pregnant (as determined by standard site practices)

  • The procedure is an emergency procedure.

  • The procedure is a revision/reoperation for the same indication.

  • The subject has a documented confounding medical condition which in the opinion of the investigator, will not be appropriate for the study, or the subject has an estimated life expectancy of less than 6 months.

  • Subject has participated or plans to participate in an investigational drug or device research study that would interfere with the results of this study.

  • Subject will undergo multiple synchronous colon resections.

  • Subject with a bleeding disorder or is undergoing anticoagulant treatment that has not been reversed (anticoagulant prophylaxis prescribed as part of the surgical protocol is allowed)

  • Subject has undergone chemotherapy or received biologics within 6 weeks prior to the day of the procedure.

  • Subject has history of chronic corticosteroid use (used greater than 3 months within a year prior to the index procedure).

  • Subject has chronic immunosuppression therapy (used greater than 3 months within a year prior to the index procedure)

  • Any subject undergoing an ileal-anal pouch anastomosis surgery

Intraoperative Exclusion Criteria

  • Anastomosis not attempted with the Signia™ circular stapler.

  • Any subject for which the device is intended to be used outside the instructions for use (IFU)

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/1/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

William Perry

Contact us for the latest status

Contact information:

Cassandra Bell

(507) 422-9153

bell.cassandra@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597459

Mayo Clinic Footer